What is Chemomab Therapeutics Ltd. American Depositary Share's Enterprise Value?

Chemomab Therapeutics Ltd. American Depositary Share's Enterprise Value is $1.5B, based on as-reported figures from SEC (XBRL) filings.

Chemomab Therapeutics Ltd. American Depositary Share (CMMB) Financial Statements

Chemomab Therapeutics Ltd. American Depositary Share

SIC 2834 · PHARMACEUTICAL PREPARATIONS

FIGI BBG00N0PMH92

XNAS · usd

2.63▼ 0.12 (-4.36%)

As of 2026-09-09

Valuation

Market Cap

Enterprise Value

Trailing P/E—

Price / Sales—

EV / Revenue—

EV / EBITDA

Financial Highlights

Revenue (TTM)—

Net Income (TTM)

EBITDA

Diluted EPS (TTM)

EBITDA Margin—

Net Debt

Trading Information

Previous Close2.75

Day's Range2.66 – 2.88

52-Week Range1.35 – 3.58

Volume95.9K

Avg Volume97.0K

Share Statistics

Shares Outstanding

Employees12

ExchangeXNAS

Listed2021-03-17

Share count as of June 30, 2026

ViewDetail

Period

Loading Income Statement…

Key questions about Chemomab Therapeutics Ltd. American Depositary Share (CMMB)

What is Chemomab Therapeutics Ltd. American Depositary Share's Market Cap?: Chemomab Therapeutics Ltd. American Depositary Share's Market Cap is $1.5B, based on as-reported figures from SEC (XBRL) filings.
What is Chemomab Therapeutics Ltd. American Depositary Share's Enterprise Value?: Chemomab Therapeutics Ltd. American Depositary Share's Enterprise Value is $1.5B, based on as-reported figures from SEC (XBRL) filings.
What is Chemomab Therapeutics Ltd. American Depositary Share's EV / EBITDA?: Chemomab Therapeutics Ltd. American Depositary Share's EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.
What is Chemomab Therapeutics Ltd. American Depositary Share's Net Income (TTM)?: Chemomab Therapeutics Ltd. American Depositary Share's Net Income (TTM) is -$7.6M, based on as-reported figures from SEC (XBRL) filings.
What is Chemomab Therapeutics Ltd. American Depositary Share's EBITDA?: Chemomab Therapeutics Ltd. American Depositary Share's EBITDA is -$335.9M, based on as-reported figures from SEC (XBRL) filings.
What is Chemomab Therapeutics Ltd. American Depositary Share's Diluted EPS (TTM)?: Chemomab Therapeutics Ltd. American Depositary Share's Diluted EPS (TTM) is -0.01, based on as-reported figures from SEC (XBRL) filings.
What is Chemomab Therapeutics Ltd. American Depositary Share's Net Debt?: Chemomab Therapeutics Ltd. American Depositary Share's Net Debt is -$6.0M, based on as-reported figures from SEC (XBRL) filings.